Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice

Angiotensin-converting enzyme 2 (ACE2) is the established cellular receptor for SARS-CoV-2. However, it is unclear whether ACE1 inhibitors (e.g., lisinopril) or angiotensin receptor blockers (e.g., losartan) alter tissue ACE2 expression. This study sought to determine whether lisinopril or losartan,...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Steven D., Smith, Rachel L., Moreira, Aline S., Ackerman, Hans C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961328/
https://www.ncbi.nlm.nih.gov/pubmed/35359831
http://dx.doi.org/10.3389/fphar.2022.798349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961328/
https://www.ncbi.nlm.nih.gov/pubmed/35359831
http://dx.doi.org/10.3389/fphar.2022.798349

Ejemplares similares